{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:48:04Z","timestamp":1787892484538,"version":"build-2784847793"},"reference-count":97,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.drudis.2024.104186","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T01:14:51Z","timestamp":1726794891000},"page":"104186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Application of proteomics for novel drug discovery and risk prediction optimisation in stroke and myocardial infarction: a review of in-human studies"],"prefix":"10.1016","volume":"29","author":[{"given":"Richard J.","family":"Webb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Al-Asmakh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Mazidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2024.104186_b0005","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/elps.11501601185","article-title":"Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium","volume":"16","author":"Wasinger","year":"1995","journal-title":"Electrophoresis"},{"key":"10.1016\/j.drudis.2024.104186_b0010","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/pmic.201400582","article-title":"The 20th anniversary of proteomics and some of its origins","volume":"15","author":"Humphery-Smith","year":"2015","journal-title":"Proteomics"},{"key":"10.1016\/j.drudis.2024.104186_b0015","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/jim-2016-000186","article-title":"Proteomics in stroke research: potentials of the nascent proteomics","volume":"64","author":"Zhou","year":"2016","journal-title":"J Investig Med"},{"key":"10.1016\/j.drudis.2024.104186_b0020","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1093\/eurheartj\/ehaa661","article-title":"Proteomics for personalized cardiovascular risk assessment: in pursuit of the Holy Grail","volume":"41","author":"Ganz","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.drudis.2024.104186_b0025","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41573-022-00409-3","article-title":"The emerging role of mass spectrometry-based proteomics in drug discovery","volume":"21","author":"Meissner","year":"2022","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.drudis.2024.104186_b0030","first-page":"1832","article-title":"An in vitro investigation of the effects of urolithins A and B on low-density lipoprotein uptake and its regulatory genes","volume":"19","author":"Ganjali","year":"2023","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.drudis.2024.104186_b0035","first-page":"203","article-title":"The effect of PCSK9 immunization on the hepatic level of microRNAs associated with PCSK9\/LDLR pathway","volume":"19","author":"Ataei","year":"2023","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.drudis.2024.104186_b0040","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3389\/fgene.2019.01075","article-title":"Sequence-derived markers of drug targets and potentially druggable human proteins","volume":"10","author":"Ghadermarzi","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.drudis.2024.104186_b0045","unstructured":"World Stroke Organization (2022). Global stroke fact sheet. www.world-stroke.org\/news-and-blog\/news\/wso-global-stroke-fact-sheet-2022 [Accessed September 16, 2024]."},{"key":"10.1016\/j.drudis.2024.104186_b0050","doi-asserted-by":"crossref","first-page":"7609","DOI":"10.3390\/ijms21207609","article-title":"Pathophysiology and treatment of stroke: present status and future perspectives","volume":"21","author":"Kuriakose","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2024.104186_b0055","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/CIRCRESAHA.122.320110","article-title":"Stroke proteomics: from discovery to diagnostic and therapeutic applications","volume":"130","author":"Hochrainer","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.drudis.2024.104186_b0060","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.mpmed.2020.06.002","article-title":"Stroke: causes and clinical features","volume":"48","author":"Murphy","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.drudis.2024.104186_b0065","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/ijms19020498","article-title":"Mass spectrometry-based proteomic profiling of thrombotic material obtained by endovascular thrombectomy in patients with ischemic stroke","volume":"19","author":"Mu\u00f1oz","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2024.104186_b0070","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1161\/STROKEAHA.120.032129","article-title":"Combined omic analyzes of cerebral thrombi: a new molecular approach to identify cardioembolic stroke origin","volume":"52","author":"Suissa","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.drudis.2024.104186_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105421","article-title":"Plasma protein alterations during human large vessel stroke: a controlled comparison study","volume":"160","author":"Hazelwood","year":"2022","journal-title":"Neurochem Int"},{"key":"10.1016\/j.drudis.2024.104186_b0080","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/neurintsurg-2020-016118","article-title":"Proteomic changes in intracranial blood during human ischemic stroke","volume":"13","author":"Maglinger","year":"2021","journal-title":"J Neurointerv Surg"},{"key":"10.1016\/j.drudis.2024.104186_b0085","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12883-023-03253-z","article-title":"Inflammator-associated proteomic predictors of cognitive outcome in subjects with ELVO treated by mechanical thrombectomy","volume":"23","author":"Maglinger","year":"2023","journal-title":"BMC Neurol"},{"key":"10.1016\/j.drudis.2024.104186_b0090","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/NEN.0b013e3181f8c539","article-title":"The proteome of human brain after ischemic stroke","volume":"69","author":"Cuadrado","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.drudis.2024.104186_b0095","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jprot.2013.08.017","article-title":"Quantitative clinical proteomic study of autopsied human infarcted brain specimens to elucidate the deregulated pathways in ischemic stroke pathology","volume":"91","author":"Datta","year":"2013","journal-title":"J Proteomics"},{"key":"10.1016\/j.drudis.2024.104186_b0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jprot.2013.09.005","article-title":"From brain to blood: new biomarkers for ischemic stroke prognosis","volume":"94","author":"Garc\u00eda-Berrocoso","year":"2013","journal-title":"J Proteomics"},{"key":"10.1016\/j.drudis.2024.104186_b0105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1074\/mcp.RA117.000419","article-title":"Single cell immuno-laser microdissection coupled to label-free proteomics to reveal the proteotypes of human brain cells after ischemia","volume":"17","author":"Garc\u00eda-Berrocoso","year":"2018","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.drudis.2024.104186_b0110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12916-022-02408-y","article-title":"Identification of novel proteins for lacunar stroke by integrating genome\u2013wide association data and human brain proteomes","volume":"20","author":"Zhang","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.drudis.2024.104186_b0115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12967-022-03377-9","article-title":"Identifying causal genes for stroke via integrating the proteome and transcriptome from brain and blood","volume":"20","author":"Wu","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.drudis.2024.104186_b0120","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2174\/1570159X18666200528143301","article-title":"The stroke-induced blood-brain barrier disruption: current progress of inspection technique, mechanism, and therapeutic target","volume":"18","author":"Okada","year":"2020","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.drudis.2024.104186_b0125","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1021\/pr501324n","article-title":"Proteomic signature of endothelial dysfunction identified in the serum of acute ischemic stroke patients by the iTRAQ-based LC-MS approach","volume":"14","author":"Sharma","year":"2015","journal-title":"J Proteome Res"},{"key":"10.1016\/j.drudis.2024.104186_b0130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11010-019-03501-2","article-title":"Distinct proteomic profiles in monozygotic twins discordant for ischaemic stroke","volume":"456","author":"Vadgama","year":"2019","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.drudis.2024.104186_b0135","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12967-019-1962-8","article-title":"Proteomic profiling of plasma biomarkers in acute ischemic stroke due to large vessel occlusion","volume":"17","author":"Qin","year":"2019","journal-title":"J Transl Med"},{"key":"10.1016\/j.drudis.2024.104186_b0140","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1161\/STROKEAHA.115.010829","article-title":"Discovery of new risk markers for ischemic stroke using a novel targeted proteomics chip","volume":"46","author":"Lind","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.drudis.2024.104186_b0145","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1161\/STROKEAHA.121.038349","article-title":"Longitudinal study reveals long-term proinflammatory proteomic signature after ischemic stroke across subtypes","volume":"53","author":"Stanne","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.drudis.2024.104186_b0150","doi-asserted-by":"crossref","first-page":"e2182","DOI":"10.1212\/WNL.0000000000207242","article-title":"Plasma proteomic associations with incident ischemic stroke in older adults: the cardiovascular health study","volume":"100","author":"Kalani","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.drudis.2024.104186_b0155","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/1354750X.2018.1434681","article-title":"Verification of a proteomic biomarker panel to diagnose minor stroke and transient ischaemic attack: phase 1 of SpecTRA, a large scale translational study","volume":"23","author":"Penn","year":"2018","journal-title":"Biomarkers"},{"key":"10.1016\/j.drudis.2024.104186_b0160","article-title":"Plasma protein profile of incident myocardial infarction, ischemic stroke, and heart failure in 2 cohorts","volume":"10","author":"Lind","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.drudis.2024.104186_b0165","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCULATIONAHA.119.040180","article-title":"Novel drug targets for ischemic stroke identified through Mendelian randomization analysis of the blood proteome","volume":"140","author":"Chong","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.drudis.2024.104186_b0170","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.1038\/s41467-022-33675-1","article-title":"Systematic Mendelian randomization using the human plasma proteome to discover potential therapeutic targets for stroke","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2024.104186_b0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-022-05165-3","article-title":"Stroke genetics informs drug discovery and risk prediction across ancestries","volume":"611","author":"Mishra","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2024.104186_b0180","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/STROKEAHA.117.017236","article-title":"Inflammatory stroke extracellular vesicles induce macrophage activation","volume":"48","author":"Couch","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.drudis.2024.104186_b0185","doi-asserted-by":"crossref","first-page":"24024","DOI":"10.1038\/s41598-021-03497-0","article-title":"Proteomic analysis of extracellular vesicles enriched serum associated with future ischemic stroke","volume":"11","author":"Mitaki","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2024.104186_b0190","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1179\/1743132811Y.0000000038","article-title":"Proteomic analysis shows differential protein expression in endothelial progenitor cells between healthy subjects and ischemic stroke patients","volume":"33","author":"Brea","year":"2011","journal-title":"Neurol Res"},{"key":"10.1016\/j.drudis.2024.104186_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158287","article-title":"Platelets proteomic profiles of acute ischemic stroke patients","volume":"11","author":"Cevik","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2024.104186_b0200","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jocn.2022.11.006","article-title":"Comparative proteomic analysis of ventricular and cisternal cerebrospinal fluid in haemorrhagic stroke patients","volume":"107","author":"Hopkins","year":"2023","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.drudis.2024.104186_b0205","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s41593-021-00886-6","article-title":"Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders","volume":"24","author":"Yang","year":"2021","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.drudis.2024.104186_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035879","article-title":"Urinary proteomics to support diagnosis of stroke","volume":"7","author":"Dawson","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2024.104186_b0215","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.drudis.2024.104186_b0220","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12872-023-03231-w","article-title":"The global prevalence of myocardial infarction: a systematic review and meta-analysis","volume":"23","author":"Salari","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.drudis.2024.104186_b0225","series-title":"Myocardial infarction","author":"Ojha","year":"2023"},{"key":"10.1016\/j.drudis.2024.104186_b0230","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3892\/ijmm.2020.4600","article-title":"Proteomic landscape of human coronary artery atherosclerosis","volume":"46","author":"Zhou","year":"2020","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.drudis.2024.104186_b0235","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2337\/dc19-1902","article-title":"Coronary artery disease and type 2 diabetes: a proteomic study","volume":"43","author":"Ferrannini","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.drudis.2024.104186_b0240","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3429541","article-title":"Plasma proteome profiling of coronary artery disease patients: downregulation of transthyretin\u2013an important event","volume":"2020","author":"Monu","year":"2020","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.drudis.2024.104186_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2021.104449","article-title":"Quantitative proteomics reveals differential immunoglobulin\u2013associated proteome (IgAP) in patients of acute myocardial infarction and chronic coronary syndromes","volume":"252","author":"Tan","year":"2022","journal-title":"J Proteomics"},{"key":"10.1016\/j.drudis.2024.104186_b0250","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ehf2.14465","article-title":"Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial","volume":"11","author":"Santos-Ferreira","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.drudis.2024.104186_b0255","doi-asserted-by":"crossref","first-page":"8574","DOI":"10.1038\/s41598-022-12385-0","article-title":"Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction","volume":"12","author":"Girerd","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2024.104186_b0260","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1186\/s12864-022-08811-2","article-title":"Mendelian randomization of circulating proteome identifies actionable targets in heart failure","volume":"23","author":"Moncla","year":"2022","journal-title":"BMC Genomics"},{"key":"10.1016\/j.drudis.2024.104186_b0265","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.jacc.2023.09.804","article-title":"Plasma proteomics to identify drug targets for ischemic heart disease","volume":"82","author":"Mazidi","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.drudis.2024.104186_b0270","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014333","article-title":"FURIN expression in vascular endothelial cells is modulated by a coronary artery disease-associated genetic variant and influences monocyte transendothelial migration","volume":"9","author":"Yang","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.drudis.2024.104186_b0275","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.117.029443","article-title":"Application of large-scale aptamer-based proteomic profiling to planned myocardial infarctions","volume":"137","author":"Jacob","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.drudis.2024.104186_b0280","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"Collet","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.drudis.2024.104186_b0285","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.3390\/ijms24098097","article-title":"Potential biomarkers to distinguish type 1 myocardial infarction in troponin-elevated diseases","volume":"24","author":"Kwon","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2024.104186_b0290","first-page":"559","article-title":"A look to the past - what has had the biggest impact on lipids in the last four decades? A personal perspective","volume":"19","author":"Banach","year":"2023","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.drudis.2024.104186_b0295","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeac039","article-title":"The role of inflammation and the possibilities of inflammation reduction to prevent cardiovascular events","volume":"2","author":"Maierean","year":"2022","journal-title":"Eur Heart J Open"},{"key":"10.1016\/j.drudis.2024.104186_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2020.103796","article-title":"Proteomic analysis detects deregulated reverse cholesterol transport in human subjects with ST-segment elevation myocardial infarction","volume":"222","author":"Das","year":"2020","journal-title":"J Proteomics"},{"key":"10.1016\/j.drudis.2024.104186_b0305","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ejvs.2023.01.035","article-title":"Plasma lipoprotein lipase is associated with risk of future major adverse cardiovascular events in patients following carotid endarterectomy","volume":"65","author":"Mekke","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.drudis.2024.104186_b0310","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/eurjpc\/zwad020","article-title":"Proteomic profiling identifies novel independent relationships between inflammatory proteins and myocardial infarction","volume":"30","author":"Valdes-Marquez","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.drudis.2024.104186_b0315","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/2048872612441582","article-title":"Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease","volume":"1","author":"Badimon","year":"2012","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.drudis.2024.104186_b0320","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.3390\/ijms24076523","article-title":"Targeted blood plasma proteomics and hemostasis assessment of post COVID-19 patients with acute myocardial infarction","volume":"24","author":"Kalinskaya","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2024.104186_b0325","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1002\/pmic.201000708","article-title":"Proteomic changes related to \u201cbewildered\u201d circulating platelets in the acute coronary syndrome","volume":"11","author":"L\u00f3pez-Farr\u00e9","year":"2011","journal-title":"Proteomics"},{"key":"10.1016\/j.drudis.2024.104186_b0330","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/ATVBAHA.121.317113","article-title":"Neutrophil-derived protein S100A8\/A9 alters the platelet proteome in acute myocardial infarction and is associated with changes in platelet reactivity","volume":"42","author":"Joshi","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.drudis.2024.104186_b0335","doi-asserted-by":"crossref","first-page":"8991","DOI":"10.1038\/s41598-019-45473-9","article-title":"Proteomic profiling of extracellular vesicles reveals additional diagnostic biomarkers for myocardial infarction compared to plasma alone","volume":"9","author":"Gidl\u00f6f","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2024.104186_b0340","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.cca.2011.02.030","article-title":"Time course proteomic profiling of human myocardial infarction plasma samples: an approach to new biomarker discovery","volume":"412","author":"Silbiger","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.drudis.2024.104186_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106171","article-title":"Identification of patient subtypes based on protein expression for prediction of heart failure after myocardial infarction","volume":"26","author":"Heyse","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.drudis.2024.104186_b0350","article-title":"A plasma proteomic approach in patients with heart failure after acute myocardial infarction: insights into the pathogenesis and progression of the disease","volume":"10","author":"Liu","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.drudis.2024.104186_b0355","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jprot.2011.06.028","article-title":"Proteomic analysis of plasma samples from patients with acute myocardial infarction identifies haptoglobin as a potential prognostic biomarker","volume":"75","author":"Haas","year":"2011","journal-title":"J Proteomics"},{"key":"10.1016\/j.drudis.2024.104186_b0360","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cca.2012.11.019","article-title":"Proteomic analysis of adverse outcomes in patients with acute coronary syndromes","volume":"416","author":"Dong","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.drudis.2024.104186_b0365","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ejhf.980","article-title":"Circulating proteins as predictors of incident heart failure in the elderly","volume":"20","author":"Stenemo","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.drudis.2024.104186_b0370","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10557-020-07047-0","article-title":"Beneficial effects of Baduanjin exercise on left ventricular remodelling in patients after acute myocardial infarction: an exploratory clinical trial and proteomic analysis","volume":"35","author":"Mao","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.drudis.2024.104186_b0375","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-076415","article-title":"Protocol of the Berlin Long-term Observation of Vascular Events (BeLOVE): a prospective cohort study with deep phenotyping and long-term follow up of cardiovascular high-risk patients","volume":"13","author":"Weber","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.drudis.2024.104186_b0380","article-title":"Prediction models for cardiovascular disease risk in the general population: systematic review","volume":"353","author":"Damen","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.drudis.2024.104186_b0385","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.jacc.2021.08.018","article-title":"Proteomics-enabled deep learning machine algorithms can enhance prediction of mortality","volume":"78","author":"Unterhuber","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.drudis.2024.104186_b0390","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2016.5951","article-title":"Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart disease","volume":"315","author":"Ganz","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.drudis.2024.104186_b0395","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1093\/eurheartj\/ehaa648","article-title":"Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention","volume":"41","author":"Hoogeveen","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.drudis.2024.104186_b0400","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/eurheartj\/ehac055","article-title":"Targeted proteomics improves cardiovascular risk prediction in secondary prevention","volume":"43","author":"Nurmohamed","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.drudis.2024.104186_b0405","article-title":"A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk","volume":"14","author":"Williams","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.drudis.2024.104186_b0410","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jclinepi.2023.06.013","article-title":"Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review","volume":"160","author":"Manyara","year":"2023","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.drudis.2024.104186_b0415","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ebiom.2018.12.033","article-title":"Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery disease","volume":"39","author":"Bom","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.drudis.2024.104186_b0420","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s00392-020-01729-3","article-title":"Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial","volume":"110","author":"Ferreira","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.drudis.2024.104186_b0425","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1007\/s00125-018-4641-z","article-title":"Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes","volume":"61","author":"Nowak","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.drudis.2024.104186_b0430","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/eurheartj\/ehad115","article-title":"Proteomic cardiovascular risk assessment in chronic kidney disease","volume":"44","author":"Deo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.drudis.2024.104186_b0435","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1126\/science.1211811","article-title":"Improving validation practices in \u201comics\u201d research","volume":"334","author":"Ioannidis","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.drudis.2024.104186_b0440","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/s42255-021-00478-5","article-title":"Integrative analysis of the plasma proteome and polygenic risk of cardiometabolic diseases","volume":"3","author":"Ritchie","year":"2021","journal-title":"Nat Metabolism"},{"key":"10.1016\/j.drudis.2024.104186_b0445","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ajhg.2022.04.001","article-title":"Combining evidence from Mendelian randomization and colocalization: review and comparison of approaches","volume":"109","author":"Zuber","year":"2022","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.drudis.2024.104186_b0450","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ajhg.2022.12.017","article-title":"Using genetic association data to guide drug discovery and development: review of methods and applications","volume":"110","author":"Burgess","year":"2023","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.drudis.2024.104186_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100561","article-title":"Multi-omics profiling for health","volume":"22","author":"Babu","year":"2023","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.drudis.2024.104186_b0460","unstructured":"Olink. Olink Explore HT. https:\/\/olink.com\/products-services\/exploreht\/ [Accessed September 16, 2024]."},{"key":"10.1016\/j.drudis.2024.104186_b0465","unstructured":"SomaLogic. The SomaScan Platform. https:\/\/somalogic.com\/somascan-platform\/ [Accessed September 16, 2024]."},{"key":"10.1016\/j.drudis.2024.104186_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.xgen.2022.100195","article-title":"Proteome-wide Mendelian randomization in global biobank meta-analysis reveals multi-ancestry drug targets for common diseases","volume":"2","author":"Zhao","year":"2022","journal-title":"Cell Genomics"},{"key":"10.1016\/j.drudis.2024.104186_b0475","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012729","article-title":"Racial differences in cardiovascular biomarkers in the general population","volume":"8","author":"Hackler","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.drudis.2024.104186_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100046","article-title":"Ethical principles, constraints and opportunities in clinical proteomics","volume":"20","author":"Mann","year":"2021","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.drudis.2024.104186_b0485","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","article-title":"Clinical use of current polygenic risk scores may exacerbate health disparities","volume":"51","author":"Martin","year":"2019","journal-title":"Nat Genet"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644624003118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644624003118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T18:14:33Z","timestamp":1731521673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644624003118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":97,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1359644624003118"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2024.104186","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of proteomics for novel drug discovery and risk prediction optimisation in stroke and myocardial infarction: a review of in-human studies","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2024.104186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104186"}}